(S (NP (NP (DT The) (JJ main) (NN goal)) (PP (IN of) (NP (DT this) (NN study)))) (VP (VBZ is) (VP (VBG creating) (NP (NP (DT a) (NN method)) (PP (IN for) (NP (NP (JJ practical) (NN treatment)) (CC and) (NP (JJ diagnostic) (NNP AF))))))) (. .))
(S (NP (DT This) (NN method)) (VP (VBZ considers) (NP (CC both) (NP (NP (DT the) (NNS features)) (PP (IN of) (NP (DT the) (NN complication)))) (CC and) (NP (NP (DT the) (NNS specifics)) (PP (IN of) (NP (DT the) (JJ chronic) (NN disease)))))) (. .))
(S (NP (DT A) (NN model)) (VP (VBZ is) (VP (VBN created) (PP (VBN based) (PP (IN on) (NP (NP (NN case) (NNS histories)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN with) (NP (NN thyrotoxicosis)))))))))) (. .))
(S (NP (DT Each) (NN model)) (VP (VBZ has) (NP (NNS advantages) (CC and) (NNS disadvantages)) (PP (VBG depending) (PP (IN on) (NP (DT the) (ADJP (JJ diagnostic) (CC and) (JJ medical)) (NNS purposes))))) (. .))
